United States · FDA National Drug Code directory
Hydroxyzine Pamoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-921_2e63fa75-efcf-d9ee-e063-6394a90ab2d0
- Product NDC
- 76420-921
- Form
- CAPSULE
- Composition / generic term
- Hydroxyzine Pamoate
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19840701
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROXYZINE PAMOATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (76420-921-01) · 76420-921-01
- 500 CAPSULE in 1 BOTTLE (76420-921-05) · 76420-921-05
- 30 CAPSULE in 1 BOTTLE (76420-921-30) · 76420-921-30
- 60 CAPSULE in 1 BOTTLE (76420-921-60) · 76420-921-60
- 90 CAPSULE in 1 BOTTLE (76420-921-90) · 76420-921-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →